SPIA
MXCT icon

Steward Partners Investment Advisory’s MaxCyte MXCT Stock Holding History

Steward Partners Investment Advisory’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$118 Hold
168
– – ﹤0.01% 4341
2025
Q4 		$260 Hold
168
– – ﹤0.01% 4186
2025
Q3 		$265 Buy
+168
New +$292 ﹤0.01% 4163
2024
Q2 		– Sell
-1,630
Closed -$6.83K – 3678
2024
Q1 		$6.83K Hold
1,630
– – ﹤0.01% 2947
2023
Q4 		$7.66K Hold
1,630
– – ﹤0.01% 2809
2023
Q3 		$5.09K Buy
+1,630
New +$6.55K ﹤0.01% 2819

Other funds holding MXCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $88.9M AUM

Steward Partners Investment Advisory's MXCT Position: Q1 2026 in Review

Steward Partners Investment Advisory held its MaxCyte (MXCT) position steady in Q1 2026 at 168 shares worth $118. The position accounts for ﹤0.01% of the portfolio, ranked #4341.

Steward Partners Investment Advisory first reported a position in MXCT in Q3 2023 and has held it in 6 quarters since. The position peaked at $7.66K in Q4 2023. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • Steward Partners Investment Advisory held 168 shares of MaxCyte worth $118 as of Q1 2026.
  • Steward Partners Investment Advisory left its MaxCyte share count unchanged in Q1 2026.
  • MaxCyte made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q1 2026, its #4341 holding.
  • Steward Partners Investment Advisory first reported a position in MaxCyte in Q3 2023 and has held it in 6 quarters since.
  • Steward Partners Investment Advisory's MaxCyte position peaked at $7.66K in Q4 2023.
  • 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.